FasL-over-expressing T lymphocytes as effector cells in anti-prostate cancer gene therapy

被引：0
|
作者：
Bielawski, JC
Fowler, DH
Medin, JA
机构：
[1] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada
[2] NCI, Expt Transplantat & Immunol Branch, NIH, Bethesda, MD 20892 USA
[3] Ontario Canc Inst, Div Expt Therapeut, Toronto, ON M4X 1K9, Canada
来源：
MOLECULAR THERAPY | 2004年 / 9卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
950
引用
收藏
页码：S364 / S364
页数：1
相关论文
共 50 条
  • [21] The fibroblast growth factor receptor inhibitor PD0173074 as a potential novel anti-prostate cancer therapy
    Goldstraw, M.
    Seckl, M.
    Christmas, T.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 83 - 83
  • [22] Cancer gene therapy using mesenchymal stem cells expressing interferon-β in a mouse prostate cancer lung metastasis model
    Ren, C.
    Kumar, S.
    Chanda, D.
    Kallman, L.
    Chen, J.
    Mountz, J. D.
    Ponnazhagan, S.
    GENE THERAPY, 2008, 15 (21) : 1446 - 1453
  • [23] Cancer gene therapy using mesenchymal stem cells expressing interferon-β in a mouse prostate cancer lung metastasis model
    C Ren
    S Kumar
    D Chanda
    L Kallman
    J Chen
    J D Mountz
    S Ponnazhagan
    Gene Therapy, 2008, 15 : 1446 - 1453
  • [24] ONC201 induces cell death in androgen receptor positive prostate cancer cells and shows synergistic effect with anti-prostate cancer drugs
    Lev, Avital
    Lulla, Amriti R.
    Dicker, David T.
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2016, 76
  • [25] AD-PSES-TRAIL: A novel prostate specific trail over-expressing adenoviral vector for androgen independent prostate cancer gene therapy
    Gardner, TA
    Raikwar, SP
    Lee, SJ
    Bunde, PJ
    Li, X
    Kao, CH
    JOURNAL OF UROLOGY, 2004, 171 (04): : 164 - 164
  • [26] Engineered T cells for anti-cancer therapy
    Turtle, Cameron J.
    Hudecek, Michael
    Jensen, Michael C.
    Riddell, Stanley R.
    CURRENT OPINION IN IMMUNOLOGY, 2012, 24 (05) : 633 - 639
  • [27] Prostate cancer gene therapy using recombinant adenovirus expressing a novel tumor suppressor gene pHyde
    Steiner, MS
    Zhang, XW
    Wang, Y
    Lu, Y
    CANCER GENE THERAPY, 2000, 7 (12) : S2 - S2
  • [28] Iminoenamine based novel androgen receptor antagonist exhibited anti-prostate cancer activity in androgen independent prostate cancer cells through inhibition of AKT pathway
    Divakar, S.
    Saravanan, K.
    Karthikeya, P.
    Elancheran, R.
    Kabilan, S.
    Balasubramanian, K. K.
    Devi, Rajlakshmi
    Kotoky, J.
    Ramanathan, M.
    CHEMICO-BIOLOGICAL INTERACTIONS, 2017, 275 : 22 - 34
  • [29] Targeting gene therapy for prostate cancer cells by liposomes complexed with anti-prostate-specific membrane antigen monoclonal antibody
    Ikegami, Shusei
    Yamakami, Kazuo
    Ono, Takeshi
    Sato, Masaki
    Suzuki, Satoshi
    Yoshimura, Ichiro
    Asano, Tomohiko
    Hayakawa, Masamichi
    Tadakuma, Takushi
    HUMAN GENE THERAPY, 2006, 17 (10) : 997 - 1005
  • [30] Suicide gene therapy on LNCaP human prostate cancer cells
    Yoshimura, I
    Suzuki, S
    Tadakuma, T
    Hayakawa, M
    INTERNATIONAL JOURNAL OF UROLOGY, 2001, 8 (07) : S5 - S8
12345